Tetraphase Pharmaceuticals, Inc. (TTPH): PT Raised News

TTPH – BMO Capital raises PT to $3 from $2.75. This new price target represents a 12.78% upside over the stock’s previous closing price of $2.66.


Update: As of Dec. 14, 2018, this bullish analyst call has returned -43.23%.


Key Facts Surrounding This News Item


  • TTPH had a POWR Rating of D (Sell) coming into today.
  • TTPH was 1.95% above its 10-Day Moving Average coming into today.
  • TTPH was -16.46% below its 20-Day Moving Average coming into today.
  • TTPH was -46.86% below its 50-Day Moving Average coming into today.
  • TTPH was -52.73% below its 100-Day Moving Average coming into today.
  • TTPH was -57.71% below its 200-Day Moving Average coming into today.
  • TTPH had returned -57.78% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About Tetraphase Pharmaceuticals, Inc. (TTPH)


Tetraphase Pharmaceuticals is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create antibiotics for serious and life-threatening MDR bacterial infections. The company was founded in 2006 and is based in Watertown, Massachusetts. View our full TTPH ticker page with ratings, news, and more.

TTPH at a Glance

TTPH Current POWR Rating™
Overall POWR Rating™
TTPH Current Price $1.51 4.43%
More TTPH Ratings, Data, and News

TTPH Price Reaction

The day of this event (Mar. 8, 2018)
TTPH Closing Price$2.92 9.77%
TTPH Volume1,865,300
101.04% from avg
Leading up to this event
TTPH 1-mo return49.14%
After this event
TTPH 1-day return8.28%
TTPH 3-day return17.39%
TTPH 5-day return9.52%

TTPH Price Chart


The Top Stocks For 2019

More Tetraphase Pharmaceuticals, Inc. (TTPH) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All TTPH News
Page generated in 0.9165 seconds.